|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/28 | (2006.01) |
| A61K 9/20 | (2006.01) |
| (11) | Number of the document | 4159205 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22209107.6 |
| Date of filing the European patent application | 2011-12-20 | |
| (97) | Date of publication of the European application | 2023-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-14 |
| (46) | Date of publication of the claims translation | 2024-05-10 |
| (30) | Number | Date | Country code |
| 201061424967 P | 2010-12-20 | US |
| (72) |
DEMARINI, Douglas, J. , US
LE, Ngocdiep, T. , US
HENRIQUEZ, Francisco , US
WANG, Lihong , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Nauja farmacinė kompozicija |
| NOVEL PHARMACEUTICAL COMPOSITION |
| Payment date | Validity (years) | Amount | |
| 2025-11-21 | 15 | 289.00 EUR |
| 2026-12-20 |